Abdi Ghaffari

2.3k total citations · 1 hit paper
36 papers, 1.7k citations indexed

About

Abdi Ghaffari is a scholar working on Molecular Biology, Rehabilitation and Oncology. According to data from OpenAlex, Abdi Ghaffari has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Rehabilitation and 7 papers in Oncology. Recurrent topics in Abdi Ghaffari's work include Wound Healing and Treatments (8 papers), Mycobacterium research and diagnosis (5 papers) and Peptidase Inhibition and Analysis (5 papers). Abdi Ghaffari is often cited by papers focused on Wound Healing and Treatments (8 papers), Mycobacterium research and diagnosis (5 papers) and Peptidase Inhibition and Analysis (5 papers). Abdi Ghaffari collaborates with scholars based in Canada, United States and Iran. Abdi Ghaffari's co-authors include Aziz Ghahary, Christopher C.J. Miller, Bevin McMullin, Ruhangiz T. Kilani, Robyn Meurant, Ali Ardakani, Bruce E. Elliott, Mazyar Ghaffari, Edward E. Tredget and Jeremy Road and has published in prestigious journals such as Nature Communications, Scientific Reports and The FASEB Journal.

In The Last Decade

Abdi Ghaffari

35 papers receiving 1.7k citations

Hit Papers

A non-hallucinogenic LSD ... 2023 2026 2024 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdi Ghaffari Canada 21 538 246 237 206 184 36 1.7k
Jared Jagdeo United States 30 420 0.8× 204 0.8× 162 0.7× 81 0.4× 249 1.4× 156 2.8k
Liwen Deng United States 22 683 1.3× 269 1.1× 452 1.9× 98 0.5× 84 0.5× 42 1.9k
Weifeng He China 21 321 0.6× 239 1.0× 105 0.4× 228 1.1× 65 0.4× 55 1.4k
Xueli Wang China 25 641 1.2× 131 0.5× 261 1.1× 83 0.4× 51 0.3× 91 1.8k
Binbin Deng China 26 1.3k 2.4× 90 0.4× 424 1.8× 158 0.8× 65 0.4× 95 2.2k
Timo Ylikomi Finland 33 1.2k 2.2× 116 0.5× 355 1.5× 67 0.3× 169 0.9× 113 3.8k
Kenzo Takahashi Japan 26 1.1k 2.0× 84 0.3× 200 0.8× 85 0.4× 507 2.8× 121 2.3k
Steven Paul Nisticò Italy 31 334 0.6× 65 0.3× 392 1.7× 78 0.4× 259 1.4× 177 2.7k
Stefan Kippenberger Germany 27 804 1.5× 174 0.7× 253 1.1× 33 0.2× 539 2.9× 101 2.4k

Countries citing papers authored by Abdi Ghaffari

Since Specialization
Citations

This map shows the geographic impact of Abdi Ghaffari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdi Ghaffari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdi Ghaffari more than expected).

Fields of papers citing papers by Abdi Ghaffari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdi Ghaffari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdi Ghaffari. The network helps show where Abdi Ghaffari may publish in the future.

Co-authorship network of co-authors of Abdi Ghaffari

This figure shows the co-authorship network connecting the top 25 collaborators of Abdi Ghaffari. A scholar is included among the top collaborators of Abdi Ghaffari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdi Ghaffari. Abdi Ghaffari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bonniwell, Emma M., Abdi Ghaffari, Maggie M. Calkins, et al.. (2023). A non-hallucinogenic LSD analog with therapeutic potential for mood disorders. Cell Reports. 42(3). 112203–112203. 79 indexed citations breakdown →
3.
Ghaffari, Abdi, Sandip Sengupta, Yolanda Madarnas, et al.. (2022). Targeting the Ezrin Adaptor Protein Sensitizes Metastatic Breast Cancer Cells to Chemotherapy and Reduces Neoadjuvant Therapy–induced Metastasis. Cancer Research Communications. 2(6). 456–470. 5 indexed citations
4.
Ghaffari, Abdi, Robyn Meurant, & Ali Ardakani. (2021). COVID-19 Point-of-Care Diagnostics That Satisfy Global Target Product Profiles. Diagnostics. 11(1). 115–115. 15 indexed citations
5.
Graham, Charles H., Jean‐François Paré, Tiziana Cotechini, et al.. (2021). Innate immune memory is associated with increased disease-free survival in bladder cancer patients treated with bacillus Calmette-Guérin. Canadian Urological Association Journal. 15(8). E412–E417. 13 indexed citations
6.
Ghaffari, Abdi, Robyn Meurant, & Ali Ardakani. (2020). COVID-19 Serological Tests: How Well Do They Actually Perform?. Diagnostics. 10(7). 453–453. 102 indexed citations
7.
Robinson, C., Sandra D. MacDonald, Ann M. Peterson, et al.. (2020). Antibacterial activity of high-dose nitric oxide against pulmonary Mycobacterium abscessus disease. Access Microbiology. 2(9). acmi000154–acmi000154. 28 indexed citations
8.
Ghaffari, Abdi, Gulisa Turashvili, Sonal Varma, et al.. (2019). Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer. Breast Cancer Research. 21(1). 12–12. 33 indexed citations
9.
Ghaffari, Abdi, et al.. (2019). Synergistic Effect of Nitric Oxide with Antibiotics Against Mycobacterium Abscessus in Vitro. A2656–A2656. 2 indexed citations
10.
Ghaffari, Abdi, Nichole Peterson, Kasra Khalaj, et al.. (2018). STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer. British Journal of Cancer. 119(4). 440–449. 134 indexed citations
11.
Ghaffari, Abdi, et al.. (2018). High-dose nitric oxide as a potential new therapeutic agent against Mycobacterium abscessus. PA5463–PA5463. 2 indexed citations
12.
Azad, Taha, Helena J. Janse van Rensburg, Elizabeth D. Lightbody, et al.. (2018). A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis. Nature Communications. 9(1). 1061–1061. 127 indexed citations
13.
Ghaffari, Abdi, et al.. (2015). Ezrin regulates focal adhesion and invadopodia dynamics by altering calpain activity to promote breast cancer cell invasion. Molecular Biology of the Cell. 26(19). 3464–3479. 54 indexed citations
14.
Chávez‐Muñoz, Claudia, Ryan Hartwell, Reza B. Jalili, et al.. (2012). SPARC/SFN interaction, suppresses type I collagen in dermal fibroblasts. Journal of Cellular Biochemistry. 113(8). 2622–2632. 12 indexed citations
15.
Ghaffari, Abdi, et al.. (2011). Microarray‐based identification of aminopeptidase N target genes in keratinocyte conditioned medium‐stimulated dermal fibroblasts. Journal of Cellular Biochemistry. 113(3). 1061–1068. 6 indexed citations
16.
Miller, Christopher C.J., et al.. (2011). Gaseous nitric oxide exhibits minimal effect on skin fibroblast extracellular matrix gene expression and immune cell viability. Cell Biology International. 35(4). 407–415. 19 indexed citations
17.
Ghaffari, Abdi, et al.. (2011). Paracrine regulation of fibroblast aminopeptidase N/CD13 expression by keratinocyte-releasable stratifin. Journal of Cellular Physiology. 226(12). 3114–3120. 9 indexed citations
18.
Ghaffari, Abdi, et al.. (2006). Fibroblast extracellular matrix gene expression in response to keratinocyte‐releasable stratifin. Journal of Cellular Biochemistry. 98(2). 383–393. 59 indexed citations
19.
Miller, Christopher C.J., et al.. (2004). Treatment of Chronic Nonhealing Leg Ulceration with Gaseous Nitric Oxide: A Case Study. Journal of Cutaneous Medicine and Surgery. 8(4). 233–238. 41 indexed citations
20.
Miller, Christopher C.J., et al.. (2004). Treatment of Chronic Nonhealing Leg Ulceration with Gaseous Nitric Oxide: A Case Study. Journal of Cutaneous Medicine and Surgery. 8(4). 233–238. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026